# US Drug Infusion System Market > US Drug Infusion System Market Research Report By Product Type (Elastomeric Infusion System, Disposable Infusion System), By Application (Oncology/Chemotherapy), By Mode of Administration (Intravenous) and By End User (Hospitals) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.49% - **2024:** $ 2,500 Million - **2025:** $ 2,637.25 Million - **2035:** $ 4,500 Million - **Key Players:** Baxter International (US), B. Braun Melsungen AG (DE), Medtronic (US), Smiths Medical (US), Fresenius Kabi (DE), Terumo Corporation (JP), ICU Medical (US), Halyard Health (US), Zyno Medical (US) **Report ID:** MRFR/MED/18375-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-drug-infusion-system-market-19922 --- ## Market Summary ## **US Drug Infusion System Market Overview** As per MRFR analysis, the US Drug Infusion System Market Size was estimated at 2.12 (USD Billion) in 2023. The US Drug Infusion System Market Industry is expected to grow from 2.5(USD Billion) in 2024 to 3.75 (USD Billion) by 2035. The US Drug Infusion System Market CAGR (growth rate) is expected to be around 3.755% during the forecast period (2025 - 2035). ### **Key US Drug Infusion System Market Trends Highlighted** The US Drug Infusion System Market is experiencing significant trends shaped by technological advancements and the increasing focus on patient care. One major market driver is the growing prevalence of chronic diseases, such as diabetes and cancer, which require frequent and precise drug administration. This trend is pushing healthcare providers to adopt advanced infusion systems that enhance medication delivery efficiency and reduce the risk of errors. Additionally, there is a trend towards integrated delivery systems that allow healthcare professionals to monitor patients remotely, thus improving treatment outcomes and offering a higher level of convenience for patients. Opportunities in this market are emerging from the demand for personalized and automated infusion devices. As patients increasingly seek solutions that cater to their specific medical needs, manufacturers can explore innovations in smart infusion devices that provide real-time data and adjust dosages based on patient conditions. Furthermore, changes in healthcare regulations in the US, promoting more thorough evaluations of medical devices, can pave the way for new market entrants and foster healthy competition, pushing innovation. In recent times, there has also been a shift towards outpatient treatments and home healthcare, driven by the need for cost-effectiveness and patient comfort. Government policies supporting telehealth services further support this trend, leading to a higher demand for portable infusion systems. Consequently, the landscape of the drug infusion system market in the US is complex but full of potential, defining the way medications are administered and monitored within diverse healthcare settings. As compliance with digital health standards continues to rise, the focus on drug infusion systems is likely to grow, presenting numerous possibilities for stakeholders within the marketplace. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Drug Infusion System Market Drivers** ### **Increasing Demand for Chronic Disease Management** The rise in chronic diseases such as diabetes and hypertension in the United States is a significant driver for the US Drug Infusion System Market Industry. According to the Centers for Disease Control and Prevention (CDC), approximately 6 in 10 adults in the U.S. have a chronic disease, and 4 in 10 adults have two or more chronic diseases. This escalating prevalence necessitates efficient drug delivery systems that can provide continuous medication administration, thereby boosting the need for advanced drug infusion systems. Key players in the industry, such as Baxter International and Becton, Dickinson and Company, are actively innovating their drug infusion technologies to meet this growing demand, catering specifically to the complexities of chronic disease management. The consistent investment in Research and Development (R&D) to enhance the efficacy and safety of infusion devices is expected to elevate product uptake, thereby supporting market growth substantially in the coming years. ### **Technological Advancements in Infusion Systems** The US [Drug Infusion System Market](../../../reports/drug-infusion-system-market-6207) Industry is witnessing substantial growth driven by rapid technological advancements. Innovations such as smart infusion pumps with integrated software that helps in precise medication delivery are becoming more prevalent. For example, the introduction of devices featuring built-in safety mechanisms to prevent dosage errors has increased market confidence. The Food and Drug Administration (FDA) emphasizes the importance of such advancements in its recent approvals of novel infusion technologies. The integration of information technology and connectivity features in devices is making it easier for healthcare providers to monitor and manage drug infusions, significantly improving patient outcomes. ### **Rising Geriatric Population** The aging population in the United States is a critical factor driving the growth of the US Drug Infusion System Market Industry. According to data from the U.S. Census Bureau, the proportion of older adults is projected to rise significantly, with around 20% of the population expected to be 65 years or older by 2030. This demographic shift demands advanced healthcare solutions, including efficient drug delivery systems that can cater to the unique healthcare needs of older adults, who frequently require long-term medications. Companies like Medtronic and Johnson & Johnson are focusing their efforts on developing specialized infusion systems that address the complexities associated with geriatric care, further propelling market growth. ### **Increased Investment in Healthcare Infrastructure** The expansion of healthcare infrastructure in the United States is driving the US Drug Infusion System Market Industry significantly. The U.S. government has initiated various healthcare expansion programs aimed at improving access to treatment. For example, the Medicare program has been implementing strategies to enhance provider reimbursements for infusion therapy, which encourages healthcare facilities to adopt advanced infusion technologies. Major healthcare organizations are also investing in upgrading their facilities, leading to a greater implementation of drug infusion systems. The combined efforts of the government and private sector investments in healthcare infrastructure are expected to stimulate the demand for drug infusion systems further. ## **US Drug Infusion System Market Segment Insights** ### **Drug Infusion System Market Product Type Insights** The US Drug Infusion System Market is exhibiting considerable growth and innovation, largely driven by the evolving needs of healthcare providers and patients. Within this market, the Product Type segment displays diverse offerings that cater to various clinical applications. Elastomeric Infusion Systems are particularly gaining traction due to their ability to provide continuous drug delivery without the need for external power sources. This self-contained system typically utilizes elastomeric materials to allow controlled drug infusion over an extended period, making it ideal for outpatient settings and reducing the burden on healthcare facilities. The convenience and effectiveness in pain management and chemotherapy applications are key factors contributing to its increasing adoption. Disposable Infusion Systems also play a significant role in the market, offering a critical solution for maintaining hygiene and minimizing the risk of infections. Their one-time use eliminates the need for complex cleaning and sterilization processes, streamlining operations in hospitals and clinics. As healthcare focuses more on patient safety and infection control, the demand for disposable systems is bolstering their importance in the US Drug Infusion System Market landscape. Additionally, the trend toward home healthcare is encouraging developments in these product types, as patients are increasingly treated in their homes, where ease of use and patient empowerment become paramount. The combination of these factors indicates that both Elastomeric Infusion Systems and Disposable Infusion Systems are not only significant in terms of revenue potential but also crucial in shaping the future dynamics of the US Drug Infusion System Market. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Drug Infusion System Market Application Insights** The Application segment of the US Drug Infusion System Market is vital, particularly in the realm of Oncology and Chemotherapy. This segment has gained prominence due to the increasing prevalence of cancer diagnoses across the United States, which underscores the need for effective drug delivery systems. The advancements in technology have led to innovative drug infusion systems that ensure accurate dosing and reduce the likelihood of complications associated with chemotherapy. Additionally, growing awareness and demand for personalized medicine are driving the development of tailored solutions in drug infusion, further reinforcing the segment's significance. Furthermore, institutions are investing in Research and Development to enhance the efficacy of drug delivery systems for cancer treatment, addressing patient convenience and improving therapeutic outcomes. As healthcare infrastructure continues to evolve, the focus on improving patient care in oncology remains a priority, making the Oncology and Chemotherapy category a crucial aspect of the US Drug Infusion System Market. This segment is expected to maintain its dominance, propelled by ongoing trends that emphasize efficacy and safety in drug administration for patients undergoing cancer treatment. ### **Drug Infusion System Market Mode of Administration Insights** The Mode of Administration segment within the US Drug Infusion System Market plays a crucial role in the overall efficiency and effectiveness of medication delivery. Intravenous administration dominates this segment due to its swift onset of action, making it essential for acute care settings such as hospitals and emergency units. The US Drug Infusion System Market statistics indicate a growing reliance on intravenous methods, especially for patients requiring rapid administration of antibiotics, chemotherapy, and pain management medications. The increasing prevalence of chronic diseases and the aging population in the U.S. further fuel the demand for innovative intravenous delivery systems. Enhanced technologies, such as smart infusion pumps, are being integrated to improve medication accuracy and patient safety. Additionally, the ongoing Research and Development efforts focus on optimizing intravenous systems to ensure better patient compliance and therapeutic outcomes. However, challenges such as the risks of infection and complications remain prevalent and underline the need for stringent protocols and advanced training for healthcare providers. Thus, intravenous administration not only supports the present healthcare demands but also represents significant opportunities for advancements in drug delivery methodologies within the US landscape. ### **Drug Infusion System Market End User Insights** The US Drug Infusion System Market has seen significant developments in its End User segment, particularly within hospitals, which play a crucial role in healthcare delivery. As the primary setting for the administration of medications via infusion systems, hospitals account for a major share of usage in the market. Factors driving hospital demand include the increasing prevalence of chronic diseases that require long-term medication management, advancements in precision medicine, and the growing focus on patient-centric care. Hospitals are integrating advanced drug infusion systems to enhance patient safety and improve treatment efficiency, which aligns with the rising expectations for superior healthcare outcomes. Furthermore, continuous improvements in technology, such as smart infusion pumps that reduce medication errors and promote adherence to dosages, benefit not only clinical workflows but also patient experiences. The ongoing demand for specialized care and the expansion of outpatient services are anticipated to further bolster the importance of drug infusion systems in hospitals across the United States. This segment remains vital due to its direct impact on patient care, resource allocation, and overall healthcare efficiency in the US Drug Infusion System Market. ## **US Drug Infusion System Market Key Players and Competitive Insights** The US Drug Infusion System Market is a dynamic and rapidly evolving sector characterized by intense competition among various players. The market features an array of advanced technologies and innovative products designed to enhance the safety and efficacy of drug delivery systems. Companies are continuously striving to develop advanced infusion devices that cater to a wide range of healthcare applications, including pain management, chemotherapy, and diabetes care. The competitive landscape is shaped by factors such as technological advancements, regulatory approvals, product launches, and strategic collaborations. Companies also focus on adapting to changing healthcare needs and improving patient outcomes while managing costs, resulting in a diverse and competitive marketplace. ### **Key Companies in the US Drug Infusion System Market Include:** ## **US Drug Infusion System Market Industry Developments** The US Drug Infusion System Market has witnessed significant developments recently, particularly with advancements in technology and patient care solutions. Companies like C.R. Bard and Medtronic are increasingly focusing on innovative infusion systems that enhance patient safety and efficacy. In November 2023, Moog Inc. announced a collaboration aimed at integrating AI-driven solutions into their existing infusion systems, enhancing the precision of drug delivery. Additionally, in October 2023, Smiths Medical received FDA clearance for their new infusion pump, signaling a strong commitment to advancing infusion therapy standards. Moreover, a notable merger occurred in September 2023 when Becton Dickinson and Company acquired a subsidiary of Eitan Group for improved market access in the US, thereby expanding its capabilities in drug infusion systems. The market's valuation has been positively impacted by a rising demand for home healthcare solutions, particularly post-pandemic, with a marked increase in the use of infusion systems for chronic disease management. The growth trajectory of the US Drug Infusion System Market continues to be influenced by increased regulatory support and evolving healthcare needs, creating opportunities for key players like Fresenius Kabi and ICU Medical to expand their product offerings. ## **US Drug Infusion System Market Segmentation Insights** ### **Drug Infusion System Market Product Type Outlook** ### **Drug Infusion System Market Application Outlook** ### **Drug Infusion System Market Mode of Administration Outlook** ### **Drug Infusion System Market End User Outlook** ## Market Drivers ### Growing Focus on Patient Safety The drug infusion-system market is increasingly shaped by the growing emphasis on patient safety within healthcare settings. Hospitals and healthcare facilities are implementing stringent protocols to minimize medication errors and enhance patient care. Infusion systems equipped with safety features, such as dose error reduction systems and alarm functionalities, are becoming essential tools in this endeavor. Recent studies indicate that medication errors can lead to adverse events in up to 1.5 million patients annually in the US, underscoring the critical need for reliable infusion systems. As healthcare providers prioritize patient safety, the demand for advanced drug infusion systems that ensure accurate dosing and monitoring is likely to increase. This focus on safety not only enhances patient outcomes but also aligns with regulatory requirements, further driving the growth of the drug infusion-system market. ### Expansion of Healthcare Infrastructure The market is positively impacted by the ongoing expansion of healthcare infrastructure across the US. As new hospitals and outpatient facilities are established, the demand for advanced medical equipment, including drug infusion systems, is expected to rise. Recent reports indicate that healthcare spending in the US is projected to reach $6 trillion by 2027, reflecting a robust investment in healthcare infrastructure. This expansion creates opportunities for manufacturers and suppliers of drug infusion systems to cater to a growing customer base. Additionally, the integration of infusion systems into new healthcare facilities is likely to enhance treatment capabilities and improve patient care. As healthcare providers seek to adopt the latest technologies, the drug infusion-system market stands to benefit from this infrastructural growth, positioning itself for sustained expansion in the coming years. ### Technological Integration in Healthcare The drug infusion-system market is poised for growth due to the ongoing technological integration within the healthcare sector. Innovations such as smart infusion pumps, which offer enhanced safety features and connectivity, are becoming increasingly prevalent. These devices not only improve the accuracy of drug delivery but also facilitate real-time monitoring and data collection. The market for smart infusion systems is projected to expand significantly, with estimates suggesting a growth rate of around 10% annually. This technological evolution is likely to attract investments and drive research and development efforts, ultimately leading to the introduction of more advanced drug infusion systems. As healthcare providers prioritize patient safety and treatment efficacy, the demand for technologically advanced infusion systems is expected to rise, further propelling the drug infusion-system market. ### Increased Prevalence of Chronic Diseases The drug infusion-system market is significantly influenced by the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders. As these conditions become more common, the need for effective drug delivery systems intensifies. Data suggests that chronic diseases account for approximately 70% of all deaths in the US, highlighting the urgent need for innovative treatment solutions. Infusion systems play a crucial role in managing these diseases, providing precise and controlled delivery of medications. The market is expected to witness substantial growth as healthcare providers increasingly adopt infusion systems to enhance patient outcomes. Furthermore, advancements in drug formulation and delivery methods are likely to drive the development of more sophisticated infusion systems, catering to the specific needs of patients with chronic conditions. ### Rising Demand for Home Healthcare Solutions The drug infusion-system market experiences a notable surge in demand due to the increasing preference for home healthcare solutions. Patients are increasingly opting for at-home treatments, which necessitate the use of advanced drug infusion systems. This shift is driven by the desire for convenience, reduced hospital stays, and improved quality of life. According to recent data, the home healthcare market is projected to grow at a CAGR of approximately 8% over the next five years. This trend indicates a significant opportunity for the drug infusion-system market, as healthcare providers seek to develop systems that cater to the needs of patients in home settings. The integration of telehealth services further enhances this market, allowing for remote monitoring and management of infusion therapies, thereby expanding the reach and application of drug infusion systems in home healthcare. ## Future Outlook The [Drug Infusion System Market](https://www.marketresearchfuture.com/reports/drug-infusion-system-market-6207) is projected to grow at a 5.49% CAGR from 2025 to 2035, driven by technological advancements, increasing chronic diseases, and demand for home healthcare solutions. **New opportunities:** - Development of smart infusion pumps with IoT connectivity - Expansion of home-based infusion therapy services - Integration of AI for personalized medication delivery By 2035, the market is expected to achieve substantial growth, driven by innovation and evolving healthcare needs. ## Segment Insights ### By Product Type: Elastomeric infusion system (Largest) vs. Disposable infusion system (Fastest-Growing) In the US drug infusion-system market, the segment distribution reveals that elastomeric infusion systems hold a significant market share, serving as the primary choice for many healthcare providers due to their reliability and versatility in delivering medication. On the other hand, disposable infusion systems are gaining traction, appealing to hospitals seeking lower operational costs and heightened safety standards. This shift indicates a progressive change in preferences toward disposable solutions. Growth trends in this segment are largely driven by advancements in technology and an increased focus on patient safety and comfort. The rise of disposable systems, in particular, can be attributed to the growing demand for single-use devices that reduce infection risk and ensure higher efficiency in drug delivery. As healthcare facilities strive for cost-effective solutions, disposable infusion systems are anticipated to emerge as a leading preference in the coming years. Elastomeric infusion system (Dominant) vs. Disposable infusion system (Emerging) Elastomeric infusion systems are characterized by their self-contained units that provide accurate and consistent medication delivery over a predetermined period, making them highly valued in various clinical settings. With a dominant position in the market, they are favored for their ease of use and ability to deliver precise dosages without the need for electrical power. Conversely, disposable infusion systems are emerging as a competitive alternative, particularly in outpatient and home care environments. Their appeal lies in their affordability, reduced risk of cross-contamination, and convenience, positioning them as a practical choice for healthcare providers aiming to optimize patient outcomes while managing costs effectively. ### By Application: Oncology/Chemotherapy (Largest) vs. Diabetes (Fastest-Growing) In the US drug infusion-system market, Oncology/Chemotherapy commands the largest market share among the application segments, driven by the increasing prevalence of cancer and the demand for effective treatment options. This is closely followed by Diabetes applications, which are gaining significant traction due to the rising incidence of diabetes and the need for insulin delivery systems. Other applications like Analgesia, Nutrition, and Hematology also contribute to the market, but they lag behind in terms of market size. Growth trends indicate that the diabetes segment is the fastest-growing, propelled by advancements in technology and increased awareness of diabetes management. Additionally, the oncology segment continues to expand, fueled by innovations in chemotherapy delivery methods. With ongoing research and development, both segments are positioned for significant growth in the coming years as healthcare providers seek more efficient treatment solutions. Oncology/Chemotherapy (Dominant) vs. Diabetes (Emerging) Oncology/Chemotherapy stands as the dominant application in the US drug infusion-system market, primarily due to the critical nature of cancer treatments that often require complex drug infusion protocols. The market is characterized by a variety of products that cater to the specific needs of oncology patients, including smart infusion pumps and chemotherapy delivery systems. On the other hand, the Diabetes segment is emerging rapidly, driven by the increasing prevalence of diabetes and the growing adoption of continuous glucose monitoring and insulin delivery systems. Both segments are distinct in their operational dynamics; while oncology systems focus on acute and specialized care, diabetes infusion systems cater to chronic management, reflecting a shift toward personalized healthcare solutions. ### By Mode of administration: Intravenous (Largest) vs. Subcutaneous (Fastest-Growing) The US drug infusion-system market shows a clear distribution of market share among various modes of administration. Intravenous delivery remains the largest segment, favored for its rapid drug action and effectiveness in acute care settings. Subcutaneous administration follows suit, gaining traction due to its convenience and patient-friendly characteristics, appealing particularly in the management of chronic conditions. Other modes, while essential, occupy a smaller share of the overall market. Growth trends in this segment are significantly driven by advancements in technology and patient-centric approaches. The rise of home healthcare and self-administration devices particularly boosts the subcutaneous market, which is becoming increasingly popular. Additionally, intravenous therapies continue to expand in hospitals, prompting innovations that enhance safety and efficiency in drug delivery systems, fostering growth across the board. Intravenous (Dominant) vs. Subcutaneous (Emerging) Intravenous administration is the dominant mode in the US drug infusion-system market, renowned for its ability to deliver drugs directly into the bloodstream, providing immediate effects which are crucial during critical care. This method is widely utilized in hospitals for rapid interventions. Conversely, subcutaneous administration is emerging as a convenient alternative, particularly in outpatient settings. It allows for self-administration, which is increasingly desirable in chronic disease management. Subcutaneous systems are designed to be user-friendly, encouraging adherence to treatment regimens. As such, while intravenous remains the go-to option for immediate care, subcutaneous is rapidly developing a strong foothold, reflecting changing patient needs and healthcare delivery trends. ### By End-user: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing) In the US drug infusion-system market, hospitals dominate the end-user segment, accounting for a significant share due to their extensive patient base and advanced medical facilities. Ambulatory surgical centers also play a crucial role, increasingly capturing market share as healthcare services shift towards more outpatient settings. Diagnostic centers and other facilities represent smaller portions but are vital for specialized services, contributing to the market's diversity. The growth trend within the end-user segment is driven primarily by technological advancements and a rising demand for minimally invasive procedures. Hospitals continue to invest in innovative drug delivery systems to enhance patient outcomes, while ambulatory surgical centers are emerging as key players, capitalizing on cost efficiency and patient convenience. This shift is expected to reshape the landscape of the US drug infusion-system market. Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging) Hospitals are the dominant end-users in the US drug infusion-system market, benefiting from their established infrastructure and comprehensive care capabilities. They utilize advanced infusion technologies to manage complex cases, ensuring high-quality patient care and safety. On the other hand, ambulatory surgical centers are emerging as significant players, driven by the trend towards outpatient care. These centers provide a more streamlined and cost-effective environment for patients, facilitating shorter recovery times and reducing hospital stays. As patient preferences evolve, ambulatory surgical centers are increasingly adopting sophisticated drug infusion systems, enhancing their competitive edge against traditional hospital settings. ## Competitive Benchmarking The drug infusion-system market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for efficient healthcare solutions. Key players such as Baxter International (US), Medtronic (US), and ICU Medical (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Baxter International (US) focuses on innovation in drug delivery systems, emphasizing the integration of smart technology to improve patient outcomes. Meanwhile, Medtronic (US) is leveraging its extensive research capabilities to develop advanced infusion systems that cater to a broader range of therapeutic areas. ICU Medical (US) appears to be concentrating on strategic partnerships to expand its product offerings and enhance its distribution channels, thereby shaping a competitive environment that favors collaboration and innovation.In terms of business tactics, companies are increasingly localizing manufacturing to reduce supply chain vulnerabilities and optimize operational efficiency. The market structure is moderately fragmented, with several players vying for market share, yet the collective influence of major companies like Baxter and Medtronic creates a competitive dynamic that encourages continuous improvement and innovation. This fragmentation allows for niche players to emerge, potentially disrupting established market leaders with specialized offerings. In October Baxter International (US) announced the launch of a new infusion pump designed to enhance medication safety and streamline workflows in clinical settings. This strategic move is significant as it not only reinforces Baxter's commitment to innovation but also addresses the growing demand for safer and more efficient drug delivery systems in hospitals. The introduction of this product is likely to strengthen Baxter's competitive position in the market. In September Medtronic (US) unveiled a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its infusion systems. This collaboration is indicative of a broader trend towards digital health solutions, allowing healthcare providers to monitor patient responses in real-time, thereby improving treatment outcomes. Such strategic alliances may enhance Medtronic's market reach and appeal to a tech-savvy healthcare sector. In August ICU Medical (US) expanded its product line by acquiring a smaller firm specializing in automated infusion systems. This acquisition is pivotal as it not only diversifies ICU Medical's offerings but also positions the company to capitalize on the growing demand for automation in drug delivery. The integration of advanced technologies from the acquired firm could potentially enhance ICU Medical's competitive edge. As of November current trends in the drug infusion-system market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are increasingly shaping the landscape, fostering innovation and enhancing supply chain resilience. Looking ahead, competitive differentiation is likely to evolve, with a greater emphasis on technological advancements and reliability in supply chains, moving away from traditional price-based competition. Companies that prioritize innovation and adaptability will likely emerge as leaders in this evolving market. ## Recent News & Developments The US Drug Infusion System Market has witnessed significant developments recently, particularly with advancements in technology and patient care solutions. Companies like C.R. Bard and Medtronic are increasingly focusing on innovative infusion systems that enhance patient safety and efficacy. In November 2023, Moog Inc. announced a collaboration aimed at integrating AI-driven solutions into their existing infusion systems, enhancing the precision of drug delivery. Additionally, in October 2023, Smiths Medical received FDA clearance for their new infusion pump, signaling a strong commitment to advancing infusion therapy standards. Moreover, a notable merger occurred in September 2023 when Becton Dickinson and Company acquired a subsidiary of Eitan Group for improved market access in the US, thereby expanding its capabilities in drug infusion systems. The market's valuation has been positively impacted by a rising demand for home healthcare solutions, particularly post-pandemic, with a marked increase in the use of infusion systems for chronic disease management. The growth trajectory of the US Drug Infusion System Market continues to be influenced by increased regulatory support and evolving healthcare needs, creating opportunities for key players like Fresenius Kabi and ICU Medical to expand their product offerings. ## Report Scope | MARKET SIZE 2024 | 2500.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 2637.25(USD Million) | | MARKET SIZE 2035 | 4500.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.49% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Baxter International (US), B. Braun Melsungen AG (DE), Medtronic (US), Smiths Medical (US), Fresenius Kabi (DE), Terumo Corporation (JP), ICU Medical (US), Halyard Health (US), Zyno Medical (US) | | Segments Covered | Product Type, Application, Mode of administration, End-user | | Key Market Opportunities | Integration of smart technology enhances patient monitoring in the drug infusion-system market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation in the drug infusion-system market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the projected market valuation for the US drug infusion-system market in 2035?** A: The projected market valuation for the US drug infusion-system market in 2035 is $4500.0 Million. **Q: What was the market valuation for the US drug infusion-system market in 2024?** A: The market valuation for the US drug infusion-system market in 2024 was $2500.0 Million. **Q: What is the expected CAGR for the US drug infusion-system market during the forecast period 2025 - 2035?** A: The expected CAGR for the US drug infusion-system market during the forecast period 2025 - 2035 is 5.49%. **Q: Which product type segment had the highest valuation in the US drug infusion-system market?** A: The intravenous segment had the highest valuation in the US drug infusion-system market, ranging from $1000.0 Million to $1800.0 Million. **Q: What are the key players in the US drug infusion-system market?** A: Key players in the US drug infusion-system market include Baxter International, B. Braun Melsungen AG, Medtronic, Smiths Medical, and Fresenius Kabi. **Q: Which application segment is projected to grow significantly in the US drug infusion-system market?** A: The oncology/chemotherapy application segment is projected to grow significantly, with a valuation range of $500.0 Million to $900.0 Million. **Q: What is the valuation range for the insulin pump segment in the US drug infusion-system market?** A: The valuation range for the insulin pump segment in the US drug infusion-system market is $400.0 Million to $700.0 Million. **Q: How does the market for ambulatory surgical centers compare to hospitals in the US drug infusion-system market?** A: The market for ambulatory surgical centers is valued between $800.0 Million and $1300.0 Million, while hospitals have a valuation range of $1200.0 Million to $2200.0 Million. **Q: What is the valuation range for the peristaltic pump segment in the US drug infusion-system market?** A: The valuation range for the peristaltic pump segment in the US drug infusion-system market is $350.0 Million to $650.0 Million. **Q: What is the expected growth trend for the US drug infusion-system market by 2035?** A: The US drug infusion-system market is expected to experience growth, reaching a valuation of $4500.0 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-drug-infusion-system-market-19922*